Anti-Inflammatory Profile of Paricalcitol in Hemodialysis Patients: A Prospective, Open-Label, Pilot Study

Inflammation is a strong predictor of increased morbidity and mortality in hemodialysis (HD) patients. Paricalcitol, a selective vitamin D receptor activator used for prevention and treatment of secondary hyperparathyroidism, has shown anti‐inflammatory properties in experimental studies, although c...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical pharmacology 2013-04, Vol.53 (4), p.421-426
Hauptverfasser:	Navarro-González, Juan F., Donate-Correa, Javier, Méndez, María L., de Fuentes, Mercedes Muros, García-Pérez, Javier, Mora-Fernández, Carmen
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Aged Anti-Inflammatory Agents - pharmacology Cytokines - blood Cytokines - genetics Ergocalciferols - pharmacology Female Gene expression Hemodialysis Humans inflammation Leukocytes, Mononuclear - drug effects Leukocytes, Mononuclear - metabolism Male Middle Aged Parathyroid Hormone - blood paricalcitol peripheral blood mononuclear cells Phosphates - blood Pilot Projects Prospective Studies Renal Dialysis RNA, Messenger - metabolism Studies Tumor necrosis factor-TNF Vitamin D
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!